Evidence-Based Mental Health is a renowned academic journal focused on the critical intersection of mental health and clinical practice, dedicated to promoting and disseminating evidence-based research within the field of psychiatry. Published by the esteemed BMJ Publishing Group, this journal serves as a vital resource for clinicians, researchers, and students who seek to enhance their understanding and application of mental health research in real-world settings. With a notable Scopus ranking of #11 out of 531 in the category of Medicine: Psychiatry and Mental Health, placing it in the 98th percentile, it is recognized for its impactful contributions to the field. Though access options have transitioned, the journal's commitment to fostering high-quality, peer-reviewed content remains unwavering. As coverage has discontinued in Scopus from 1998 to 2022, the journal continues to gather pivotal insights that aid practitioners in their decision-making processes while addressing contemporary challenges in mental health care.

Welcome to the Journal of Patient-Reported Outcomes, a premier platform dedicated to advancing the field of health informatics and health information management. Published by SPRINGERNATURE since 2017, this Open Access journal allows researchers and practitioners globally to disseminate vital research findings, ensuring that insights into patient-reported outcomes reach a wider audience without barriers. With its current standing in the Q2 quartile for both Health Informatics and Health Information Management in 2023, it is positioned as a significant contributor to the healthcare research community, ranking 76th out of 138 in Medicine and 34th out of 59 in Health Professions. The journal aims to publish high-quality, peer-reviewed articles that explore innovative methodologies, enhance clinical decision-making, and ultimately improve patient care outcomes. By offering a platform for interdisciplinary collaboration, the Journal of Patient-Reported Outcomes fosters a deeper understanding of patients' perspectives in healthcare, making it an essential resource for researchers, professionals, and students alike.

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

Journal of Research in Medical Sciences is a leading open-access journal published by Wolters Kluwer Medknow Publications, dedicated to disseminating innovative research and advancements in the field of medicine. Established in 2005, the journal has earned a respectable Scopus rank of 205 out of 636 in General Medicine, placing it within the 67th percentile among its peers, indicative of its quality and influence in the field. With an Open Access policy adopted in 2015, the journal ensures that critical research findings are accessible to a global audience, thus fostering knowledge sharing and collaboration among researchers, medical professionals, and students. Operating out of Iran, the journal focuses on diverse aspects of medical science, offering a platform for emerging studies that span clinical practices to health-related outcomes. As a recognized publication in the Q3 quartile of medicine (miscellaneous) for 2023, the Journal of Research in Medical Sciences continues to play a pivotal role in promoting scholarly work and advancing medical knowledge, making it an essential resource for anyone invested in the evolution of healthcare and scientific inquiry.

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

SWISS MEDICAL WEEKLY is a leading peer-reviewed journal published by the SMW supporting association, available in both print and digital formats under open access since 2001. With an ISSN of 1424-7860 and E-ISSN 1424-3997, this journal has established itself as a crucial platform for disseminating innovative research and clinical advancements in the field of Medicine. Based in Basel, Switzerland, the journal boasts an impressive Scopus ranking of #101 among 636 in the General Medicine category, placing it in the 84th percentile and categorized in the Q3 Quartile of journals for 2023. Covering a wide range of topics relevant to contemporary medical practice and research, the SWISS MEDICAL WEEKLY serves not only as a valuable resource for healthcare professionals but also as a pivotal publication for academic researchers and students alike. By providing open access to high-quality research, it encourages knowledge sharing and fosters collaboration across borders, making significant contributions to the global medical community.

The Journal of Integrated Care, published by EMERALD GROUP PUBLISHING LTD, serves as a vital platform for scholars and practitioners engaged in the multidisciplinary fields of health, public administration, and sociology. With the ISSN 1476-9018 and E-ISSN 2042-8685, this journal has established a significant presence since its inception in 1996, and continues to contribute to the advancement of integrated care practices. The journal is ranked in the Q3 quartile for Health (social science) and Public Administration, and holds a Q2 ranking in Sociology and Political Science, reflecting its influence and relevance in these fields. With a commitment to disseminating high-quality research, the Journal of Integrated Care aims to bridge gaps among various disciplines, offering insightful analysis and innovative solutions to contemporary challenges in integrated care systems. Although Open Access options are not available, the journal's articles enrich the knowledge base of professionals, researchers, and students alike, facilitating meaningful dialogue and collaboration as it converges toward its goal of improved holistic care by 2024. For further details, visit the journal's address in the United Kingdom at Floor 5, Northspring, 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.